Pharsight

King Pharms patents expiration

1. Levoxyl patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6555581 KING PHARMS Levothyroxine compositions and methods
Feb, 2022

(2 years ago)

US7067148 KING PHARMS Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
Feb, 2022

(2 years ago)

US7101569 KING PHARMS Methods of administering levothyroxine pharmaceutical compositions
Oct, 2023

(7 months ago)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 25 May, 2001

Treatment: Method of use of administering levothyroxine

Dosage: TABLET;ORAL

How can I launch a generic of LEVOXYL before it's drug patent expiration?
More Information on Dosage

LEVOXYL family patents

Family Patents

2. Procanbid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5656296 KING PHARMS Dual control sustained release drug delivery systems and methods for preparing same
Aug, 2014

(9 years ago)

Drugs and Companies using PROCAINAMIDE HYDROCHLORIDE ingredient

Market Authorisation Date: 31 January, 1996

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

PROCANBID family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Skelaxin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7714006 KING PHARMS Methods of modifying the bioavailability of metaxalone
Dec, 2021

(2 years ago)

US7122566 KING PHARMS Metaxalone products, method of manufacture, and method of use
Feb, 2026

(1 year, 8 months from now)

Drugs and Companies using METAXALONE ingredient

Treatment: Use of metaxalone for treatment of musculoskeletal conditions; Treatment of musculoskeletal conditions

Dosage: TABLET;ORAL

How can I launch a generic of SKELAXIN before it's drug patent expiration?
More Information on Dosage

SKELAXIN family patents

Family Patents